Endometriosis - Market Insights, Epidemiology and Market Forecast - 2025

  • ID: 4410576
  • Drug Pipelines
  • 70 pages
  • DelveInsight
1 of 3
Endometriosis - Market Insights, Epidemiology and Market Forecast - 2025 provides an overview of the disease and in depth research related to Endometriosis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Endometriosis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Endometriosis for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the report highlights the frontrunners, the drivers and barriers for the Endometriosis market, as well as treatment algorithm, current treatments & advancements are included. The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Endometriosis, providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to research, the forecasted patient population of Endometriosis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Endometriosis 7MM market size is estimated to be USD XX by 2025. The report will help in enhanced understanding of the Endometriosis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage:
  • Understanding historical and forecasted epidemiological data for Endometriosis covering 7MM from 2015-2025.
  • Segment level epidemiology and market split for Endometriosis .
  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Endometriosis .
  • The report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Endometriosis market trends.
  • Thorough market distribution based on market share for Endometriosis .
Reasons to Buy:
  • The report will help in developing business strategies by understanding trends shaping and driving the Endometriosis market.
  • To understand the future market competition in the Endometriosis market and Insightful review of the key market drivers and barriers.
  • Organize sales and marketing efforts by identifying the best opportunities for Endometriosis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.
Note: Please allow up to 24 hours for delivery after payment has been made.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Report Introduction

2. Endometriosis Market Overview at a Glance
2.1. Total Market Share Distribution of Endometriosis for 7 MM in 2016
2.2. Total Market Share Distribution of Endometriosis for 7 MM in 2025

3. Endometriosis
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Endometriosis in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Endometriosis in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Endometriosis in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Endometriosis in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Endometriosis in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Endometriosis in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Endometriosis
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Endometriosis Market (2016 & 2025)

9. Endometriosis: Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About

List of Tables
Table 1: Diagnosed Cases Endometriosis in United States (2015-2025)
Table 2: Diagnosed Cases Endometriosis in Germany (2015-2025)
Table 3: Diagnosed Cases Endometriosis in France (2015-2025)
Table 4: Diagnosed Cases Endometriosis in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Endometriosis in Spain (2015-2025)
Table 6: Diagnosed Cases Endometriosis in Italy (2015-2025)
Table 7: Diagnosed Cases Endometriosis in Japan (2015-2025)
Table 8: List of Marketed Drugs for Endometriosis
Table 9: List of Pipeline Phase III Drugs for Endometriosis
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Endometriosis in USD, Million (2015-2025)
Table 17: Germany Market Size of Endometriosis in USD, Million (2015-2025)
Table 18: France Market Size of Endometriosis in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Endometriosis in USD, Million (2015-2025)
Table 20: Spain Market Size of Endometriosis in USD, Million (2015-2025)
Table 21: Italy Market Size of Endometriosis in USD, Million (2015-2025)
Table 22: Japan Market Size of Endometriosis in USD, Million (2015-2025)

List of Figures
Figure 1: Diagnosed Cases Endometriosis in United States (2015-2025)
Figure 2: Diagnosed Cases Endometriosis in Germany (2015-2025)
Figure 3: Diagnosed Cases Endometriosis in France (2015-2025)
Figure 4: Diagnosed Cases Endometriosis in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Endometriosis in Spain (2015-2025)
Figure 6: Diagnosed Cases Endometriosis in Italy (2015-2025)
Figure 7: Diagnosed Cases Endometriosis in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Endometriosis
Figure 9: List of Pipeline Phase III Drugs for Endometriosis
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Endometriosis in USD, Million (2015-2025)
Figure 17: Germany Market Size of Endometriosis in USD, Million (2015-2025)
Figure 18: France Market Size of Endometriosis in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Endometriosis in USD, Million (2015-2025)
Figure 20: Spain Market Size of Endometriosis in USD, Million (2015-2025)
Figure 21: Italy Market Size of Endometriosis in USD, Million (2015-2025)
Figure 22: Japan Market Size of Endometriosis in USD, Million (2015-2025)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll